NasdaqCM
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 3.20 T
|
Sept. 30, 2024 | USD 1.93 | -1.03% |
|
United States |
|
2 |
USD 39.45 B
|
Sept. 30, 2024 | USD 4.59 | 0.88% |
|
United States |
|
3 |
USD 22.59 B
|
Sept. 30, 2024 | USD 1.87 | 1.08% |
|
United States |
|
4 |
USD 10.95 B
|
Sept. 28, 2024 | USD 1.16 | -0.85% |
|
United States |
|
5 |
USD 10.24 B
|
Sept. 30, 2024 | USD 34.20 | 0.03% |
|
United States |
|
6 |
USD 8.97 B
|
Sept. 30, 2024 | USD 6.54 | 3.65% |
|
United States |
|
7 |
USD 4.43 B
|
Oct. 31, 2024 | USD 3.63 | -3.20% |
|
United States |
|
8 |
USD 3.85 B
|
Sept. 30, 2023 | USD 4.62 | -0.22% |
|
United States |
|
9 |
USD 3.70 B
|
Dec. 31, 2023 | USD 46.09 | 3.11% |
|
Netherlands |
|
10 |
USD 3.26 B
|
Sept. 30, 2024 | USD 10.37 | 0.39% |
|
United States |
|
11 |
USD 2.69 B
|
Sept. 30, 2024 | USD 54.20 | -7.37% |
|
United States |
|
12 |
USD 2.41 B
|
Sept. 30, 2024 | USD 35.02 | -0.71% |
|
United States |
|
13 |
USD 2.12 B
|
Sept. 30, 2024 | USD 96.54 | 4.65% |
|
United States |
|
14 |
USD 1.97 B
|
Sept. 30, 2024 | USD 19.72 | 2.18% |
|
United States |
|
15 |
USD 1.82 B
|
Sept. 30, 2024 | USD 126.96 | 1.60% |
|
Kazakhstan |
|
16 |
USD 1.72 B
|
Sept. 30, 2024 | USD 31.19 | 3.00% |
|
United States |
|
17 |
USD 1.65 B
|
Dec. 31, 2023 | USD 3.95 | -0.25% |
|
United Kingdom |
|
18 |
USD 1.46 B
|
Sept. 30, 2024 | USD 8.15 | 5.57% |
|
United States |
|
19 |
USD 1.44 B
|
Nov. 1, 2024 | USD 12.75 | -1.16% |
|
United States |
|
20 |
USD 1.37 B
|
Sept. 30, 2024 | USD 26.87 | -0.96% |
|
United States |
|
21 |
USD 1.36 B
|
Nov. 30, 2024 | USD 34.10 | -1.07% |
|
United States |
|
22 |
USD 1.25 B
|
Sept. 30, 2024 | USD 4.34 | -5.03% |
|
United States |
|
23 |
USD 1.20 B
|
Sept. 30, 2024 | USD 36.01 | 1.84% |
|
United States |
|
24 |
USD 1.18 B
|
Sept. 30, 2024 | USD 2.95 | 1.03% |
|
United States |
|
25 |
USD 1.10 B
|
Sept. 30, 2024 | USD 4.89 | -16.98% |
|
United States |
|
26 |
USD 1.00 B
|
Sept. 30, 2024 | USD 1.61 | -1.23% |
|
United States |
|
27 |
USD 897.61 M
|
Sept. 30, 2024 | USD 19.53 | -0.66% |
|
United States |
|
28 |
USD 873.72 M
|
Sept. 30, 2024 | USD 14.16 | -0.56% |
|
United States |
|
29 |
USD 868.72 M
|
Sept. 30, 2024 | USD 25.01 | 1.13% |
|
United States |
|
30 |
USD 851.91 M
|
Sept. 30, 2024 | USD 9.57 | 1.38% |
|
United States |
|
31 |
USD 794.04 M
|
Dec. 31, 2023 | USD 18.82 | 0.05% |
|
Bahamas |
|
32 |
USD 772.81 M
|
Dec. 31, 2023 | USD 8.54 | -0.70% |
|
Israel |
|
33 |
USD 694.97 M
|
Sept. 30, 2024 | USD 4.09 | 1.74% |
|
United States |
|
34 |
USD 689.16 M
|
Dec. 31, 2023 | USD 4.10 | -1.21% |
|
Canada |
|
35 |
USD 686.46 M
|
Sept. 30, 2024 | USD 14.37 | 0.77% |
|
United States |
|
36 |
USD 685.85 M
|
Dec. 31, 2023 | USD 1.80 | NA |
|
Canada |
|
37 |
USD 659.50 M
|
Sept. 30, 2024 | USD 2.66 | -1.85% |
|
United States |
|
38 |
USD 658.16 M
|
Dec. 31, 2023 | USD 1.95 | 15.38% |
|
Singapore |
|
39 |
USD 644.12 M
|
Sept. 30, 2024 | USD 13.78 | 9.11% |
|
United States |
|
40 |
USD 628.55 M
|
Sept. 30, 2024 | USD 51.66 | 1.18% |
|
United States |
|
41 |
USD 621.48 M
|
Sept. 30, 2024 | USD 11.93 | 1.45% |
|
United States |
|
42 |
USD 606.01 M
|
Sept. 29, 2024 | USD 5.27 | 0.19% |
|
United States |
|
43 |
USD 602.92 M
|
Sept. 30, 2024 | USD 24.46 | 4.31% |
|
United States |
|
44 |
USD 598.86 M
|
Sept. 30, 2024 | USD 20.34 | 1.09% |
|
United States |
|
45 |
USD 598.75 M
|
Sept. 30, 2024 | USD 17.36 | 0.99% |
|
United States |
|
46 |
USD 585.28 M
|
Sept. 30, 2024 | USD 1.53 | -3.16% |
|
United States |
|
47 |
USD 581.91 M
|
Sept. 30, 2024 | USD 2.87 | -1.03% |
|
United States |
|
48 |
USD 576.35 M
|
Dec. 31, 2023 | USD 3.94 | -0.25% |
|
China |
|
49 |
USD 541.40 M
|
Sept. 30, 2024 | USD 3.18 | 2.91% |
|
United States |
|
50 |
USD 521.26 M
|
Sept. 30, 2024 | USD 5.61 | 0.90% |
|
United States |
The company on the NasdaqCM with the highest Revenue is LM Funding America, Inc. (NasdaqCM: LMFA) at USD 3.20 T.
The company on the NasdaqCM with the lowest Revenue is NLS Pharmaceutics AG (NasdaqCM: NLSP) at USD 0.00.
The top 10 companies on the NasdaqCM by Revenue are LM Funding America, Inc., Ispire Technology Inc., Snail, Inc. Class A Common Stock, Kopin Corporation, Qurate Retail, Inc., Arko Corp., Streamline Health Solutions, Inc., Cingulate Inc., VEON Ltd. and AdaptHealth Corp..
The bottom 10 companies on the NasdaqCM by Revenue are NLS Pharmaceutics AG, NeuroSense Therapeutics Ltd., Steakholder Foods Ltd., Lightbridge Corporation, Lisata Therapeutics, Inc., Achieve Life Sciences, Inc., Dermata Therapeutics, Inc., Alpha Tau Medical Ltd., Edesa Biotech, Inc. and Autonomix Medical, Inc. Common Stock.